ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease

Along with the steatosis-associated fibrosis estimator model developed to target significant fibrosis or higher, ALADDIN-F2-VCTE ( https://aihepatology.shinyapps.io/ALADDIN1 ) uniquely supports a refined noninvasive approach to patient selection for resmetirom without the need for liver biopsy. In addition, ALADDIN-F2-Lab ( https://aihepatology.shinyapps.io/ALADDIN2 ) offers an effective alternative when VCTE is unavailable.

Authors

Institutions

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-03-27
DOI
https://doi.org/10.14309/ajg.0000000000003432
Citations
7
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
9.48
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease

Laurent Castéra, Manal F. Abdelmalek, Luis Antonio Díaz, Congxiang Shao et al.
7 citations
The American Journal of Gastroenterology
Liver Disease Diagnosis and Treatment
9.48
article

ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease

Laurent Castéra, Manal F. Abdelmalek, Luis Antonio Díaz, Congxiang Shao, Stephen A. Harrison, Terry Cheuk‐Fung Yip, Winston Dunn, Haya Omeish, Nipun Verma, Juan Pablo Arab, Marco A. Arrese, Naim Alkhouri, Junzhao Ye, Vincent Chen, Matthew Kubina, Bihui Zhong, Julie Dubourg, Ashwani Kumar Singal, Syed‐Mohammed Jafri, Grace Lai–Hung Wong, Leon Anton Adams, Ajay Duseja, Jessica Cristiu, Yousef Almahanna, Amani Bajunayd, Marina Takawy, Zhengyi Wang, Vincent Wai‐Sun Wong, Rida Nadeem, Nicholas Dunn, Sage Robert
article en
7 citations

Abstract

Along with the steatosis-associated fibrosis estimator model developed to target significant fibrosis or higher, ALADDIN-F2-VCTE ( https://aihepatology.shinyapps.io/ALADDIN1 ) uniquely supports a refined noninvasive approach to patient selection for resmetirom without the need for liver biopsy. In addition, ALADDIN-F2-Lab ( https://aihepatology.shinyapps.io/ALADDIN2 ) offers an effective alternative when VCTE is unavailable.

The American Journal of GastroenterologyVol. 121(2)
Mayo Clinic (US), University of Louisville (US), Inserm (FR), Sun Yat-sen University (CN), Pontificia Universidad Católica de Chile (CL), Chinese University of Hong Kong (HK), The University of Western Australia (AU), Virginia Commonwealth University (US), Université Paris Cité (FR), University of Michigan (US), Hôpital Beaujon (FR), WinnMed (US), Henry Ford Hospital (US), University of California San Diego (US), University of North Carolina at Pembroke (US), University of Oxford (GB), Assistance Publique – Hôpitaux de Paris (FR), Pinnacle Clinical Research (US), Conceptual Mindworks (United States) (US), Mayo Clinic in Arizona (US), University of Kansas Medical Center (US), The First Affiliated Hospital, Sun Yat-sen University (CN), University of California San Diego Medical Center (US), University of Louisville Hospital (US), Arizona Liver Health (US), Post Graduate Institute of Medical Education and Research (IN)
Life in Land
Openalex Percentile: Top 2%
Liver Disease Diagnosis and Treatment
9.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.